
This cross-sectional study examined whether perceptions of specific features of medical school culture were associated with incoming residents' intentions to report medical errors during residency. A total of 741 incoming residents reported their perceptions of psychological safety and a harmful hidden curriculum during medical school, of whom 738 met inclusion criteria. Incoming residents were also asked about their intentions to report self-performed mistakes and witnessed errors across three mistake types (i.e., near-misses, minor, and major) to three reporting targets (i.e., another resident/fellow, a program director, and an attending physician). Psychological safety was associated with intentions to report self-performed medical mistakes across all mistake severity-by-reporting target pathways and intentions to report witnessed medical errors across seven of nine pathways. A harmful hidden curriculum was associated with four of nine pathways for self-performed errors, including intentions to report near-misses and minor errors to attending physicians and program directors, and three of nine pathways for witnessed errors. These findings suggest that, beyond features of the current clinical environment, experiences from prior training environments may help explain error-reporting intentions among incoming residents.
Vaping dependence is a growing public health concern, yet existing measures may not adequately capture its multidimensional nature. This study introduces the Multidimensional Vaping Dependence Index (MVDI), a 27-item self-report instrument assessing behavioral engagement, reinforcement, and loss of control. Items were developed from general addiction models, nicotine and tobacco dependence research, and vapingspecific literature and refined through expert review. Exploratory and confirmatory factor analyses in 530 adults who reported vaping (99.4% at least weekly) supported a three-factor structure: Vaping Preoccupation, Vaping Reinforcement, and Loss of Control. Convergent validity was demonstrated through positive correlations with established vaping dependence measures. Concurrent validity was supported by positive associations with vaping frequency, e-liquid nicotine concentration, and self-perceived addiction to vaping. Incremental validity analyses indicated that the MVDI, Vaping Preoccupation, and Vaping Reinforcement explained additional variance in vaping outcomes beyond established dependence measures, while Loss of Control was uniquely associated with self-perceived addiction. Overall, findings provide initial evidence that the MVDI is a valid and psychometrically sound multidimensional measure that offers both a general index of vaping dependence and specific subscales for research and clinical assessment, potentially informing targeted intervention and evaluation efforts.
There is a dearth of research that evaluates the generalizability of substance use disorder treatment outcomes. We assess one-month follow-up survey results and evaluate generalizability of outcomes for individuals randomly selected after discharge from a non-profit treatment center. The sample consisted of discharged patients (N = 6771). Follow-up measures were: alcohol/drug abstinence, self-reported health, quality of life, peer-recovery group attendance, follow-up treatment receipt, medication use, and craving. Descriptive and logistic regression analyses compared patients who were randomly selected to those not selected, and follow-up respondents to non-respondents; 10 measures (demographic, treatment- and diagnosis-related measures) were used to assess selection and nonresponse. A survey weight was generated that accounted for selection, and response/attrition. Outcomes were estimated using weights, and these estimates were compared to unweighted values. Weighted abstinence rate one month after treatment was 76.4% (95% CI = 74.4%, 78.4%); unweighted rate was 78.2% (95% CI = 76.4%, 79.9%). Eight out of the 10 measures used to assess survey response significantly predicted response. All 6 outcome measures were statistically similar across weighted and unweighted analyses. One-month follow-up results were representative of daily discharged population at a single US-based treatment center. Centers should use sampling designs that ensure generalizability and provide full methodological details when reporting follow-up measures.